MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.ajkd.2013.02.370

Медицинская библиотека · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2013

C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Zand Ladan, Kattah Andrea, Fervenza Fernando C, Smith Richard J H, Nasr Samih H, Zhang Yuzhou, Vrana Julie A, Leung Nelson, Cornell Lynn D, Sethi Sanjeev

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

C3 glomerulonephritis (GN) is a proliferative GN resulting from glomerular deposition of complement factors due to dysregulation of the alternative pathway of complement. Dysregulation of the alternative pathway of complement may occur as a result of mutations or functional inhibition of complement-regulating proteins. Functional inhibition of the complement-regulating proteins may result from a monoclonal gammopathy.

STUDY

DESIGN

Case series.

SETTING &

PARTICIPANTS

32 Mayo Clinic patients with C3 GN, 10 (31%) of whom had evidence of a monoclonal immunoglobulin in serum.

OUTCOMES: Clinical features, hematologic and bone marrow biopsy findings, kidney biopsy findings, kidney measures, complement pathway abnormalities, treatment, and follow-up of patients with C3 GN that was associated with a monoclonal gammopathy.

RESULTS

Mean age of patients with C3 GN associated with monoclonal gammopathy was 54.5 years. Bone marrow biopsy done in 9 patients revealed monoclonal gammopathy of undetermined significance in 5 patients, small lymphocytic lymphoma/chronic lymphocytic leukemia in one patient, and no abnormal clones in the other 3 patients. Kidney biopsy showed membranoproliferative GN with bright capillary wall C3 staining in all 10 patients. Evaluation of the alternative pathway of complement showed abnormalities in 7 of 9 patients tested. No mutation in complement-regulating proteins was detected in any patient. As an index case, one patient with C3 GN and chronic lymphocytic leukemia was treated with rituximab, cyclophosphamide, vincristine, and prednisone, and one patient with C3 GN and monoclonal gammopathy of undetermined significance was treated with dexamethasone and bortezomib. Both patients showed significant decreases in hematuria and proteinuria and stabilization of kidney function.

LIMITATIONS: Studies to show evidence of direct activation of the alternative pathway by monoclonal immunoglobulin were not done.

CONCLUSIONS

The study highlights the association of C3 GN and monoclonal gammopathy, in particular in the older population, and the importance of targeting the underlying hematologic malignancy as an approach to treating C3 GN.

Для цитирования: Zand Ladan, Kattah Andrea, Fervenza Fernando C, Smith Richard J H, Nasr Samih H, Zhang Yuzhou, Vrana Julie A, Leung Nelson, Cornell Lynn D, Sethi Sanjeev. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013. DOI: 10.1053/j.ajkd.2013.02.370.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.